Home News Mystery of great white sharks 'disappearing' from Cape Town coast – BBC News

Mystery of great white sharks 'disappearing' from Cape Town coast – BBC News

by Moin Uddin Ahmed Tipu

For years, one of South Africa’s great tourist attractions has been the opportunity to see great white sharks up close.

But barely any great white sharks have been spotted off the coast of Cape Town, South Africa for two years now – where there used to be hundreds.

What’s going on?

Please subscribe HERE


Leave a Comment


Edgar H February 14, 2021 - 6:12 PM

Whites, still apartheid?

philip formby February 14, 2021 - 6:12 PM

Overfishing the ocean is dying

Will H February 14, 2021 - 6:12 PM

Stop blaming Orcas. The warming of oceans has led to great whites and Orcas having more run ins. Humans have killed millions more great whites than Orcas ever had.

SUPE SUPE February 14, 2021 - 6:12 PM

They have all migrated to us in Australia. We have white sharks everywhere.

JASON'S WORLD February 14, 2021 - 6:13 PM

They all left across the Atlantic to the Chesapeake Bay.

Mayson February 14, 2021 - 6:14 PM

The (killer) Wales eat the sharks insides, kidneys ect. This is known. Do people not realise the ocean is HUGE and creatures migrate. These people need to get a life.

ben31uk February 14, 2021 - 6:16 PM

Time to cancel your tv license direct debit

Move to streaming services

Time up ⏰

Bill 'mad dog' Gates February 14, 2021 - 6:17 PM

I imagine a world where we will be eating Gates branded fish fingers, first I will buy out Birdseye, then I will remonopolies the whole sea food industry. 🙂

ben31uk February 14, 2021 - 6:17 PM

Time to cancel your tv license direct debit 🔥

Move to streaming services

Time up 🗑

Patrick Larry February 14, 2021 - 6:18 PM

Who cares..

Daniel Perez February 14, 2021 - 6:19 PM

Is there other white sharks in other parts of the world?

Axel Wakler February 14, 2021 - 6:20 PM

There is no pandemic and there is no covid. The chinese government and governments from around the world have worked together to pull of this mass deception in order to bring in a global dystopian police state and to secure their positions of power.

Karezza Kenosis February 14, 2021 - 6:21 PM

Are there any Chinese in the area?

Francisco Zurbaran February 14, 2021 - 6:21 PM

No to vaccine passports, disgraceful. Sign the parliament petition.

TINFOIL HAZMAT REBORN February 14, 2021 - 6:23 PM

Still not reporting about vaccine deaths then?

Cue crazy pro vaxxers.

francis king February 14, 2021 - 6:23 PM

Who cares there are plenty of white shark other areas.. this is dumb

NFAK February 14, 2021 - 6:24 PM
Caliboyk February 14, 2021 - 6:24 PM

They obviously knew about COVID-19 🦠 and said ✌️🦈

In the name of _________…

Neil Wilde February 14, 2021 - 6:26 PM

Defund the BBC

DAW Williams February 14, 2021 - 6:28 PM

The Asharkteid era has well and truly begun.

Rootytoottoot February 14, 2021 - 6:31 PM

Constantly bugging them with tourists in cages screaming at them, boat noises, petrol and oil and attracting them with dodgy fish food etc can't have helped. Hmmm? Maybe they got sick of feeling exploited for profit? Went another 10 km off shore for some peace and quiet?

Oliver Sparks February 14, 2021 - 6:32 PM

Hungry Orcas

HER MAJESTY'S CONVID POLICE February 14, 2021 - 6:32 PM

They all went to the Sharka Khan concert.

Empire Reviews Company February 14, 2021 - 6:34 PM

Dint be mad just be glad they got better people that don't kill ppl

nio england February 14, 2021 - 6:36 PM

its good to hear a different problem nation eating all the animals, its usually china

OnDayRelease February 14, 2021 - 6:37 PM

This is so sad 💔
Hope the don't become extinct in the future

Azteac Eagle February 14, 2021 - 6:41 PM

The Latin America natural resources is for the American people no only for you elon musk 🧤 🔋🔋🔋 for your electric 🚗 tesla

Lee Garrett February 14, 2021 - 6:47 PM

A combination of China and orca's!

stevexNYCperformance February 14, 2021 - 6:49 PM

Great white sharks.

clebmedia February 14, 2021 - 6:49 PM

I knew it was fish and chips from Australia that was to blame!!

par w February 14, 2021 - 6:50 PM

We humans are the most dangerous creatures. We disturb and destroy ecosystem around us. If a human reborn as a shark then he/she will release this dangerous situation.

Aztec Eagle February 14, 2021 - 6:51 PM

They have already conquered us, colonized, enslaved, invaded, displaced, they screwed us up so much that even my fear was also stolen from me The problem is not me, you or him

Araz Iranmehr February 14, 2021 - 6:52 PM
paul hoskin February 14, 2021 - 6:53 PM

They've all painted themselves black

Nasya Alencia February 14, 2021 - 6:56 PM

Hello, meet me from the planet Pluto 😆

Gary Rumain February 14, 2021 - 7:04 PM

Any Chinese fishing fleets in the area?

Mobbdeepak McMacaveli Shakoor February 14, 2021 - 7:05 PM

Seroquel Scandals
Early on, the company had a history of playing it safe. In the 1970s, Astra saw the future of antidepressants. It developed the first selective serotonin reuptake inhibitor (SSRI) called zimelidine, and began selling it 1982. But the drug produced a rare side effect that could damage the nervous system, and the company recalled it a year later. By recalling zimelidine, it avoided potential catastrophic losses from possible lawsuits.

But it had already received harsh criticism for its involvement in scandals for its blockbuster antipsychotics, Seroquel and Seroquel XR. Critics say the company was more focused on maximizing profits while it still had the patent on the drug than on patient and trial participant safety.

In addition to paying $350 million to resolve more than 23,000 lawsuits that allege Seroquel can cause diabetes, the company paid to settle illegal marketing charges. It also faced a number of scandals including corrupt data in studies for marketing the drug to children, a sex scandal and a poorly run clinical trial that could have compromised patient safety and data reliability.

Marketing Seroquel for Children
Dr. Melissa DelBello was the lead author of a ground-breaking 2002 study that found AstraZeneca’s atypical antipsychotic Seroquel (quetiapine) was safe for use in children. AstraZeneca financed the study which included 30 children diagnosed with bipolar disorder. In the end, only eight children taking Seroquel completed the trial, and DelBello determined the study was inconclusive

However, the study was published anyway and concluded Seroquel was more effective in children than a test group not receiving the drug. The publication led to a national recommendation that atypical antipsychotics be the leading choice for children with bipolar disorder.

AstraZeneca covered up study results that revealed Seroquel was either inconclusive or harmful.
Other studies involving Seroquel produced inconclusive or harmful results. Those were never published. It was later revealed that AstraZeneca systematically covered up the results. A company email used as evidence in a court case revealed: “Thus far, we have buried trials 15, 31, 56. The larger issue is how do we face the outside world when they begin to criticize us for suppressing data.”

In 2002, U.S. Sen. Charles Grassley criticized DelBello for receiving at least $238,000 in consulting fees and travel costs from AstraZeneca.

After years of investigations, AstraZeneca paid a $520 million fine brought by the U.S. Department of Justice for promoting Seroquel for unapproved uses. The company also paid $647 million to settle global lawsuits for failing to warn the public of Seroquel’s side effects.

‘Sex-for-Studies’ Seroquel Scandal
In 2009, a Florida lawsuit claimed then U.S. medical director for Seroquel Dr. Wayne MacFadden had sexual relationships with a clinical researcher who wrote journal articles favorable to Seroquel and a medical marketer who promoted Seroquel. The case was one of 9,000 claiming people developed diabetes and gained weight while on the drug.

Plaintiffs said these relationships were improper because research was supposed to be independent of AstraZeneca. MacFadden also had sexual relationships with employees of competitors and asked for trade secrets, CBS News and MedPage Today reported.

“The mere existence of these relationships calls into question the integrity of the scientific work product of those involved,” according to documents written by plaintiffs’ attorneys in 2009.

E-mails also surfaced showing AstraZeneca’s publications manager John Tumas buried three clinical trials with unfavorable Seroquel clinical data.

Poorly Organized Clinical Trial
In 2014, a Seroquel XR trial for borderline personality disorder headed by Dr. S. Charles Schultz faced scrutiny because of poor oversight, the New York Times reported. AstraZeneca paid Schultz, the head of the department of psychiatry at the University of Minnesota, to conduct the trial. In addition, he received more than $112,000 for “speaking and consulting fees and other payments” from 2002 to 2007.

Because of lack of supervision, two participants at a facility for sex offenders were able to fake their way into the trial. One of these men slipped Seroquel XR to unsuspecting staff and residents. The men were removed from the trial, but no one followed up with an investigation.

Following the Seroquel XR trial debacle, Schultz stepped down as head of psychiatry at the university.

Despite the sloppy trial and about one third of the participants dropping out because of side effects, results published in the American Journal of Psychiatry showed the drug as a promising treatment for borderline personality disorder. AstraZeneca didn’t pursue formal approval from the FDA, however.

Prior to this trial, the University of Minnesota ran a Seroquel trial in 2004, and one participant, Dan Markingson, committed suicide while on the drug.

AstraZeneca’s Drug Side Effect Litigation
In addition to AstraZeneca’s antipsychotic controversy, it also faced growing legal problems from some of its blockbuster medications. People who took some of the company’s best-selling drugs say the drugmaker failed to warn of side effects.

Crestor 10mg Pills
Crestor 10mg pill
The cholesterol drug Crestor (rosuvastatin) is used to prevent or treat heart disease, heart attacks and strokes.

People harmed by Crestor took AstraZeneca to court, claiming in lawsuits the drug contained dangerous defects. A consumer advocacy group also called for the recall of Crestor from the U.S. market but no recall was ordered.

Onglyza & Kombiglyze XR
Onglyza 5mg Pills
Onglyza 5mg pill
The FDA approved Onglyza (saxagliptin) in 2009 to treat Type 2 diabetes. AstraZeneca and partner Bristol-Myers Squibb made hundreds of millions of dollars annually from Onglyza, but a study reported Onglyza increased the risk of hospitalizations due to heart failure. The FDA warned of the increased risk in April 2015.

A month later, a woman claimed her mother died from heart failure caused by Onglyza and filed a lawsuit against AstraZeneca. Now more lawsuits are mounting for Onglyza and heart failure.

Farxiga 10mg pill
Farxiga 10mg pill
The FDA rejected Bristol-Myers and AstraZeneca’s once-daily Farxiga (dapagliflozin) before approving it in 2014. The FDA had originally denied it because data in studies showed a possible risk of bladder cancer.

After the FDA released several warnings linking the drug to serious side effects, numerous law firms are analyzing cases from people who suffered from ketoacidosis, kidney problems, UTIs or other conditions possibly caused by Farxiga…

Mobbdeepak McMacaveli Shakoor February 14, 2021 - 7:05 PM

Protonix: People are suing Pfizer over Protonix. Protonix lawsuits say Pfizer failed to warn about the risk of kidney problems. In 2013, Pfizer agreed to pay $55 million to settle criminal charges. The U.S. Department of Justice said Wyeth promoted Protonix for unapproved uses in 2000 and 2001. Pfizer acquired Wyeth in 2009.
Prempro:Nearly 10,000 women filed Prempro breast cancer lawsuits against Pfizer. By 2012, Pfizer settled most of the claims for more than $1 billion.
Chantix:About 3,000 people filed Chantix lawsuits against Pfizer. They claimed Chantix caused suicidal thoughts and severe psychological disorders. In 2013, the company set aside about $288 million to resolve these cases. One case settled for an undisclosed amount just before trial in 2012.
Depo-Testosterone:More than 6,000 testosterone therapy lawsuits were pending in May 2018. The lawsuits say testosterone products caused strokes, blood clots and heart attacks.
Effexor:A federal panel closed the consolidated Effexor litigation in 2013. Lawsuits claimed birth defects.
Zoloft:A judge dismissed Zoloft cases in 2016. Lawsuits included similar claims to Effexor XR. The judge did not disagree that Zoloft caused birth defects. But the judge concluded there was insufficient evidence to definitively link the two.
Eliquis:A judge dismissed a group of federal Eliquis cases in 2017. Injured patients continue to file severe bleeding claims in Delaware state court.
Lipitor:A judge dismissed Lipitor lawsuits in 2017. Women who took the drug filed lawsuits after developing Type 2 diabetes. There is currently an appeal pending.
Pfizer Drug RecallsPfizer has had to recall some of its popular products due to quality issues and poor packaging. Effexor XR and Prempro are two products affected by recalls.
Prempro:In 2013, Pfizer announced it was recalling five lots of Prempro. Prempro is a hormone replacement therapy drug. Routine testing revealed the strength of the drug was low.
Effexor XR:In 2014, Pfizer recalled two lots of its antidepressant drug Effexor XR. Tikosyn was discovered in an Effexor XR bottle. Tikosyn is one of the company’s heart pills. Pfizer warned that the combination of the two different drugs could be deadly.
Pfizer ScandalIn 1996, Pfizer conducted an unapproved clinical trial. It involved children with meningitis in Nigeria, CBS News reported. The trials led to the deaths of 11 children. Dozens more were left disabled.


The unauthorized trial involved tests on 200 children with Pfizer's antibiotic Trovan.

Source: BBC News

Trovan is a drug severely restricted in use because of its potential to cause liver damage. Injury to the liver as a result of taking Trovan can lead to liver failure and death.

In 2011, Pfizer paid $700,000 to four families who lost children during the Trovan trials.

In addition, the company set up a $35 million fund for those affected by Trovan. Pfizer also agreed to sponsor health projects in Kano, Nigeria

Mobbdeepak McMacaveli Shakoor February 14, 2021 - 7:05 PM

Juries in several US states have found that Janssen Pharmaceutical and its parent company Johnson & Johnson deceptively promoted the antipsychotic drug Risperdal(risperidone). By 2012, four states had been awarded damages, including Louisiana ($258 million in 2010), South Carolina ($327 million in 2011), Texas ($158 million in 2012), and most notably Arkansas ($1.2 billion in 2012) – whose Attorney General stated: “These two companies put profits before people, and they are rightfully being held responsible for their actions".

In a related issue, Risperdal sales practices resulted in a 2012 provisional settlement totaling $2.3 billion. The United States Department of Justice began investigating Risperdal sales practices in 2004, and in 2010 joined a whistleblowers suit alleging bribes paid to Omnicare the largest company supplying pharmaceutical drugs to nursing homes. The allegations include that Johnson & Johnson and Janssen were warned by the U.S. Food and drug administration (FDA) not to promote Risperdal as effective and safe for elderly patients when in fact it is associated with early death, but they did so; and that they in fact bribed Omnicare pharmacists tens of millions of dollars to promote the drug to care home physicians for this unapproved use. A settlement was provisionally agreed with Johnson & Johnson of around $2.2 billion for this and related allegations, with Omnicare having already settled for around $100 million. Former head of sales and president of Janssen, Alex Gorsky, who the Dept of Justice say “was actively involved” in the fraud, nevertheless became the new CEO of Johnson & Johnson in 2012.

sparticale1954 February 14, 2021 - 7:05 PM

What, no virus all the other die offs have been put down to this. There is a very large Elephantine in the room, go on make a guess?

Mobbdeepak McMacaveli Shakoor February 14, 2021 - 7:05 PM

If you type into Google, Rockefeller Foundation lockstep pdf and you got to the second result titled Scenarios for the future of technology and international development (which is a 54 page document) and go to page 18 you will see the that this was all planned long ago. The document used to be available on the Rockefeller Foundation website but they appear to have removed it and left some kind of disclaimer, reassuring us that they are the good guys and that they are not trying to introduce a global police state, also I'm not being allowed to post the link to the document.

Rockefeller Foundation



A world of tighter top-down government control and more

authoritarian leadership, with limited innovation and growing

citizen pushback

In 2012, the pandemic that the world had been
anticipating for years finally hit. Unlike 2009’s

H1N1, this new influenza strain—originating from wild geese—was extremely virulent and deadly. Even the most pandemic-prepared nations were quickly overwhelmed when the virus streaked around the world, infecting nearly 20 percent of the global population and killing 8 million in just seven months, the majority of them healthy young adults. The pandemic also

had a deadly effect on economies: international mobility of both people and goods screeched to

a halt, debilitating industries like tourism and
breaking global supply chains. Even locally, normally bustling shops and office buildings sat empty for months, devoid of both employees and customers.

The pandemic blanketed the planet—though disproportionate numbers died in Africa, Southeast Asia, and Central America, where the virus spread like wildfire in the absence of official containment protocols. But even in developed countries, containment was a challenge. The United States’s initial policy of
“strongly discouraging” citizens from flying proved deadly in its leniency, accelerating the

spread of the virus not just within the U.S. but across borders. However, a few countries did

fare better—China in particular. The Chinese government’s quick imposition and enforcement

of mandatory quarantine for all citizens, as well as its instant and near-hermetic sealing off of all borders, saved millions of lives, stopping the spread of the virus far earlier than in other countries and enabling a swifter post-pandemic recovery.
(This is just a small section, if you go to page 18 of the pdf document and start from there, the whole plan is written out.)

Mobbdeepak McMacaveli Shakoor February 14, 2021 - 7:06 PM

(Taken from the Tony Blair Institute for Global Change TBIGC Ltd website)
summary, governments should:

Implement a mobility credential linked to a secure and user-centric digital identity to allow the safe reopening of close-proximity spaces.

Adopt a secure and user-centric model of digital identity that puts individuals in control and protects their privacy. (🐂💩) For users this would most likely mean a biometrically secured app on their phone that stores digital credentials.

Create a platform to securely issue credentials based on test results. For example, someone would present their digital ID when being tested; a unique credential based on their results would then be sent to their app.

Agree internationally interoperable standards for credentials so that they can be widely recognised by a range of organisations. When required, users would present a mobility credential on their app to be scanned and verified.

Set out a technical, legal and liability framework for identity providers, credential-issuing parties (e.g. testing labs) and verifiers to accelerate delivery.

Set the right framework for how credentials are used in practice, in order to secure broad-based public support.

For public settings, enforce access based on a mobility credential in the highest-risk settings first, e.g. care homes and airports. As rapid point-of-use tests become more available, credential-based access can become more widespread.

Mobbdeepak McMacaveli Shakoor February 14, 2021 - 7:06 PM

What the BBC forgot to mention about tocilizumab:

Actemra Lawsuit
Patients who are currently taking or have taken the arthritis drug Actemra (tocilizumab) may meet the criteria for a lawsuit against manufacturer Genentech and its parent company Roche. Attorneys are evaluating claims that the drug’s maker failed to properly warn patients about increased risks of heart failure, stroke, pancreatitis, lung disease and gastrointestinal perforation.

Signs of trouble with Actemra (tocilizumab) first made headlines in 2009, when Chugai Pharmaceuticals, a Japanese company that originally developed the drug, reported 15 deaths among 5,000 patients who’d taken the drug for rheumatoid arthritis.

The company also reported 221 adverse reactions among users. And a Chugai spokesman told The Wall Street Journal that the company could not rule out a “causal relationship” between the drug and the deaths.

At the time, Roche, the Swiss pharmaceutical giant that includes Chugai and Genentech as subsidiaries, downplayed the reports. A company spokesman said the death rates were consistent with the number of fatalities you’d normally see among patients with rheumatoid arthritis and were in keeping with death rates of patients taking other biologic drugs.

But safety concerns heightened in 2017, when an investigation by Boston-based STAT news reported that more than 1,100 patients in the United States had died while taking Actemra.

STAT’s investigation found that hundreds of people using the medication died from heart problems, lung disorders and strokes. Thousands more suffered other serious side effects.

Other RA drugs carry warnings about the life-threatening complications, but Actemra’s label does not. The revelations could pave the way for lawsuits against the drug’s maker.

STAT Investigation Reveals More Deaths
STAT analyzed more than half a million side effects reported for Actemra and other RA drugs, such as Enbrel, Humira and Remicade. The news organization found that the rate of complications was “as high or higher” for Actemra when compared to its competitors — yet, patients were never warned about the potential risks.

Other RA drugs do contain warnings about the risk heart and lung problems.

Between 2010 and 2016, thousands of patients suffered serious side effects while taking Actemra. This included:
Heart Attacks: 410 cases
Strokes: 359 cases
Heart Failure: 224 cases
Interstitial Lung Disease: 224 cases
Pancreatitis: 132 cases
Food and Drug Administration documents obtained by STAT under a Freedom of Information Act request show that government regulators were aware of these potentially fatal side effects during post-marketing surveillance of the drug. But in most cases, the “serious, unlabeled adverse events” could not be conclusively linked to Actemra.

A 2013 report from the FDA’s Center for Drug Evaluation Research and Therapy acknowledged 91 reported heart attacks — including 21 deaths — among patients taking the drug. The report even noted that some of those heart attacks had occurred while patients were getting the drug administered, or shortly thereafter.

The report also noted that the medication can cause an increase in cholesterol levels “which may contribute to the risk of cardiac events.” But because the patients had other risk factors for a heart attack, including obesity, high blood pressure and smoking, it could not conclude that the drug was the cause.

Studies Raise Red Flags on Pancreatitis
Recent studies have also raised concerns about serious side effects not included on Actemra’s label. In a 2016 study in the Journal of Clinical Pharmacology and Therapeutics, German doctors described the “first well-documented case” of tocilizumab-induced acute pancreatitis. Pancreatitis is a serious inflammation of the pancreas that can be deadly.

The physicians said a 40-year-old patient taking the drug had developed upper abdominal pain and other clinical signs and symptoms of acute pancreatitis over the course of two days. The man improved, however, when he ceased taking the medication. The doctors concluded that tocilizumab was the “probable” cause of his pancreatic inflammation.

Looking at the FDA’s FAERS database and other studies, the physicians found 55 other cases of acute pancreatitis associated with the use of Actemra. They concluded that more studies should be performed to “confirm and quantify” the risk and that doctors “should be aware of the probable association” between Actemra use and acute pancreatitis.

A 2013 report from the FDA’s Center for Drug Evaluation and Research recommended “continued monitoring” of Actemra for several “potential safety issues,” including reported cases of pancreatitis, liver damage, blood clots and low blood counts.
Source: FDA document obtained in STAT investigation
FDA Identifies Potential Safety Issues
In January 2018, the FDA announced on its website that it was “evaluating the need for action” because of adverse event reports involving Actemra and cases of pancreatitis and liver damage.

Six months later, the agency stated it was considering regulatory action of Actemra — and four other drugs that inhibit Interleukin-1 and Interleukin-6 — because of adverse reports of serious lung problems among patients. The reports included cases of pulmonary hypertension, interstitial lung disease, and a rare, potentially fatal disease called pulmonary alveolar proteinosis, or PAP.

An October 2018 search of the FDA Adverse Event Reporting System revealed 27,858 adverse events associated with Actemra. The FDA deemed more than 21,000 as serious cases. At least 1,821 involved death.

The cases included 1,784 cardiac disorders, more than 6,000 gastrointestinal disorders and more than 4,000 respiratory reactions.

Mobbdeepak McMacaveli Shakoor February 14, 2021 - 7:09 PM

Related Posts